Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -28.63%1.74B | -3.48%727.17M | -42.60%330.94M | -23.40%472.22M | -57.38%209.43M | -6.10%2.44B | -6.46%753.36M | -17.09%576.55M | -12.95%616.43M | 26.93%491.34M |
| Cost of revenue | -69.15%352.89M | -71.06%82.56M | -65.53%72.08M | -65.73%109.01M | -73.08%89.26M | -22.55%1.14B | -18.21%285.26M | -50.03%209.08M | -21.48%318.05M | 8.80%331.52M |
| Gross profit | 7.20%1.39B | 37.71%644.61M | -29.56%258.86M | 21.73%363.21M | -24.81%120.17M | 15.61%1.29B | 2.52%468.09M | 32.67%367.47M | -1.55%298.38M | 93.97%159.82M |
| Operating expense | -2.71%888.27M | 39.54%228.65M | -79.77%59.75M | 63.77%381.22M | -1.03%218.65M | 20.87%912.98M | -25.41%163.86M | 30.00%295.44M | 5.98%232.77M | 148.89%220.91M |
| Operating profit | 30.94%498.58M | 36.72%415.96M | 176.42%199.11M | -127.45%-18.01M | -61.20%-98.48M | 4.69%380.78M | 28.40%304.24M | 44.88%72.03M | -21.37%65.61M | -859.95%-61.09M |
| Net non-operating interest income (expenses) | -29.22%-14.16M | -33.03%-4.61M | 74.58%-740K | -127.12%-6.44M | -35.72%-2.37M | -42.70%-10.96M | 4.76%-3.46M | -56.93%-2.91M | -38.34%-2.84M | -1,191.85%-1.74M |
| Non-operating interest income | -97.85%18K | -99.63%3K | -1,100.00%-100K | --108K | -12.50%7K | 10,375.00%838K | --820K | 42.86%10K | --0 | 700.00%8K |
| Non-operating interest expense | 7.70%7.09M | -6.07%2.55M | -105.06%-68K | 142.89%3.35M | 10.18%1.26M | 33.68%6.58M | 39.46%2.72M | 4.10%1.35M | -10.87%1.38M | 738.24%1.14M |
| Total other finance cost | 35.96%7.09M | 31.42%2.06M | -55.08%708K | 119.62%3.2M | 82.68%1.12M | 88.70%5.21M | -7.23%1.57M | 176.49%1.58M | --1.46M | --612K |
| Net investment income | 115.80%180K | 105.35%20K | 297.56%163K | -700.00%-150K | 117.69%147K | 45.92%-1.14M | 58.49%-374K | 109.28%41K | 107.14%25K | -101.21%-831K |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 11.53%-13.85M | 91.59%-330K | -15.24M | 181.65%9.58M | -7.87M | 98.92%-15.66M | -2,180.23%-3.92M | 0 | -293,525.00%-11.74M | 0 |
| Less:Restructuring and mergern&acquisition | --10.14M | --330K | --9.81M | ---4.16M | --4.16M | --0 | --0 | --0 | --0 | --0 |
| Less:Other special charges | -76.30%3.71M | --0 | --5.43M | ---5.43M | --3.71M | 2,283.96%15.66M | --3.92M | --0 | ---- | ---- |
| Other non-operating income (expenses) | -95.91%316K | -567.68%-767K | 21.32%8.16M | -1,156.93%-7.02M | -133.33%-58K | 766.26%7.73M | -68.40%164K | 1,041.77%6.73M | 405.99%664K | 17,300.00%174K |
| Income before tax | 30.58%471.07M | 38.31%410.28M | 152.28%191.45M | -142.60%-22.04M | -71.08%-108.62M | 133.13%360.76M | 27.45%296.64M | 132.82%75.89M | -36.00%51.72M | 94.58%-63.49M |
| Income tax | 58.41%158.71M | 19.30%97M | 1,461.31%385M | -1,893.24%-305.78M | 23.31%-17.51M | 74.36%100.19M | 32.32%81.3M | 411.98%24.66M | 413.15%17.05M | -3,923.62%-22.83M |
| Net income | 19.87%312.36M | 45.48%313.28M | -477.83%-193.55M | 718.40%283.75M | -124.06%-91.12M | 122.73%260.57M | 25.71%215.34M | 122.94%51.23M | -55.26%34.67M | 96.53%-40.67M |
| Net income continuous operations | 19.88%312.36M | 45.48%313.28M | -477.82%-193.55M | 718.40%283.75M | -124.06%-91.12M | 122.73%260.57M | 25.70%215.34M | 122.94%51.23M | -55.26%34.67M | 96.53%-40.67M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 19.87%312.36M | 45.48%313.28M | -477.83%-193.55M | 718.40%283.75M | -124.06%-91.12M | 122.73%260.57M | 25.71%215.34M | 122.94%51.23M | -55.26%34.67M | 96.53%-40.67M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 19.87%312.36M | 45.48%313.28M | -477.83%-193.55M | 718.40%283.75M | -124.06%-91.12M | 122.73%260.57M | 25.71%215.34M | 122.94%51.23M | -55.26%34.67M | 96.53%-40.67M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 42.13%7.59 | 44.28%15.1381 | -566.58%-9.355 | 911.03%13.75 | -178.37%-4.44 | 111.82%5.34 | 54.92%10.4922 | 122.81%2.005 | -56.06%1.36 | 96.55%-1.595 |
| Diluted earnings per share | 41.97%7.56 | 44.28%15.1381 | -568.26%-9.3886 | 912.95%13.75 | -178.37%-4.44 | 111.79%5.325 | 55.92%10.4922 | 122.80%2.005 | -55.55%1.3574 | 96.55%-1.595 |
| Dividend per share | 140.00%3 | 140.00%3 | 0 | 0 | 0 | 1.25 | 1.25 | |||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |